Personal Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.03M | Buy |
3,679
+96
| +3% | +$52.9K | 0.01% | 213 |
|
|
2022
Q3 | $1.82M | Buy |
3,583
+180
| +5% | +$91.3K | 0.01% | 208 |
|
|
2022
Q2 | $1.85M | Sell |
3,403
-65
| -2% | -$35.3K | 0.01% | 212 |
|
|
2022
Q1 | $2.05M | Sell |
3,468
-86
| -2% | -$50.8K | 0.01% | 218 |
|
|
2021
Q4 | $2.34M | Buy |
3,554
+1,050
| +42% | +$691K | 0.01% | 220 |
|
|
2021
Q3 | $1.43M | Buy |
2,504
+39
| +2% | +$22.3K | 0.01% | 239 |
|
|
2021
Q2 | $1.24M | Buy |
2,465
+69
| +3% | +$34.8K | 0.01% | 246 |
|
|
2021
Q1 | $1.09M | Sell |
2,396
-24
| -1% | -$10.9K | 0.01% | 252 |
|
|
2020
Q4 | $1.13M | Buy |
2,420
+455
| +23% | +$212K | 0.01% | 244 |
|
|
2020
Q3 | $868K | Buy |
1,965
+31
| +2% | +$13.7K | 0.01% | 253 |
|
|
2020
Q2 | $701K | Buy |
1,934
+310
| +19% | +$112K | 0.01% | 240 |
|
|
2020
Q1 | $393K | Buy |
1,624
+233
| +17% | +$56.4K | ﹤0.01% | 267 |
|
|
2019
Q4 | $452K | Buy |
1,391
+504
| +57% | +$164K | ﹤0.01% | 274 |
|
|
2019
Q3 | $258K | Buy |
887
+97
| +12% | +$28.2K | ﹤0.01% | 311 |
|
|
2019
Q2 | $232K | Buy |
790
+5
| +0.6% | +$1.47K | ﹤0.01% | 296 |
|
|
2019
Q1 | $215K | Buy |
+785
| New | +$215K | ﹤0.01% | 310 |
|
|
2018
Q2 | – | Sell |
-1,019
| Closed | -$210K | – | 284 |
|
|
2018
Q1 | $210K | Buy |
+1,019
| New | +$210K | ﹤0.01% | 252 |
|